Governor Hochul’s veto of LLC Transparency Act welcomed by NFIB

Ashley Ranslow - New York State Director - LinkedIn
Ashley Ranslow - New York State Director - LinkedIn
0Comments

The National Federation of Independent Business (NFIB) has commended New York Governor Kathy Hochul for vetoing the LLC Transparency Act, a bill that would have introduced new reporting requirements and penalties for small businesses in the state. The NFIB, which represents more than 11,000 members in New York, issued a statement through its State Director, Ashley Ranslow.

“NFIB thanks Governor Kathy Hochul for exercising her veto today to protect tens of thousands of New York small businesses from the litany of heavy-handed reporting requirements and fines this legislation sought to impose on Main Street. The LLC Transparency Act intentionally targets small employers with new regulations while providing specific exceptions for many big businesses and corporations. The deck is already stacked too often against the small businesses that create jobs and vibrancy in neighborhoods and communities across our state. The Governor’s action today provides welcome reprieve from yet another redundant, costly, and excessive burden,” Ranslow stated.

The NFIB has been an advocate for small and independent business owners nationwide for over eight decades. As a nonprofit organization founded in 1943, it operates in all 50 states and continues to focus exclusively on supporting these enterprises. More information about their activities can be found at nfib.com.



Related

Richard Ball, Commissioner

Dairy Promotion Order Advisory Board schedules public meetings for March

The Dairy Promotion Order Advisory Board has announced it will hold a meeting on Wednesday, March 11 at 1:30 p.m. and Thursday, March 12 at 7:30 a.m. The sessions are open to the public and will take place at several locations across New York State.

Anthony DiGiorgio, Assistant Professor of Neurological Surgery, UCSF

UCSF professor flags $1.34B Minnesota 340B windfall, as scrutiny grows over New York’s use of the program

A new Minnesota 340B report suggests the program is generating billion-dollar revenue for hospitals and driving consolidation rather than supporting safety-net care, according to UCSF assistant professor Anthony DiGiorgio.

Fred Roeder, Managing Director of the Consumer Choice Center

Consumer Choice Center releases analysis on 340B drug program’s flaws, as reform debate grows in New York

On February 10, 2026, the Consumer Choice Centre released an analysis of the 340B Drug Discount Program by Fred Roeder, raising concerns about its structure and calling for potential reforms as scrutiny around the program grows.

Trending

The Weekly Newsletter

Sign-up for the Weekly Newsletter from Empire State Today.